ZYOMYX
closedZyomyx develops and commercializes diagnostic platforms, including a point-of-care test for HIV/AIDS.
Launch date
Employees
Market cap
-
Enterprise valuation
$57—85m (Dealroom.co estimates Jul 2013.)
Fremont California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $560k | Seed | |
$12.0m | Series B | ||
| N/A | $14.2m | Late VC | |
| N/A | $7.5m | Grant | |
| Total Funding | $34.3m | ||